Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria

Diabetologia

Volumn 49, Issue 5, 2006, Pages 945-952

  Rapp, K ^a   Schroeder, J ^b   Klenk, J ^a   Ulmer, H ^c,d   Concin, H ^c   Diem, G ^c   Oberaigner, W ^e   Weiland, S K ^a  

^a UNIVERSITY OF ULM   (Germany)

^b IL   (United States)

^c AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e Tyrolean State Hospitals Ltd   (Austria)

Author keywords

Bladder cancer; Breast cancer; Epidemiology; Gallbladder cancer; Glucose; Liver cancer; Multiple myeloma; Non Hodgkin's lymphoma; Thyroid cancer

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRIA; BILE DUCT CANCER; BLADDER CANCER; BODY MASS; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COLORECTAL CANCER; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; GLUCOSE BLOOD LEVEL; HAZARD ASSESSMENT; HUMAN; HYPERGLYCEMIA; LIVER CANCER; MAJOR CLINICAL STUDY; MELANOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OCCUPATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SKIN CANCER; SMOKING; THYROID CANCER;

ADULT; AUSTRIA; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; FASTING; FEMALE; HUMANS; MALE; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT;

EID: 33646404099     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0207-6     Document Type: Article

References (41)

1. Wideroff L, Gridley G, Mellemkjaer L et al (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360-1365
2. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160-1167
3. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70:950-953
4. Adami HO, McLaughlin J, Ekbom A et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307-314
5. Ragozzino M, Melton LJ III, Chu CP, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35:13-19
6. Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147:816-825
7. Hu FB, Manson JE, Liu S et al (1999) Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91:542-547
8. Weiderpass E, Gridley G, Nyren O, Ekbom A, Persson I, Adami HO (1997) Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst 89:660-661
9. Adami HO, Chow WH, Nyren O et al (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472-1477
10. Schoen RE, Tangen CM, Kuller LH et al (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91:1147-1154
11. Muti P, Quattrin T, Grant BJ et al (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11:1361-1368
12. Manjer J, Kaaks R, Riboli E, Berglund G (2001) Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur J Cancer Prev 10:33-42
13. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156:349-352
14. Hsing AW, Gao YT, Chua S Jr, Deng J, Stanczyk FZ (2003) Insulin resistance and prostate cancer risk. J Natl Cancer Inst 95:67-71
15. Balkau B, Barrett-Connor E, Eschwege E, Richard JL, Claude JR, Ducimetiere P (1993) Diabetes and pancreatic carcinoma. Diabet Metab 19:458-462
16. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283:2552-2558
17. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J (1990) Post-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 131:254-262
18. Saydah SH, Loria CM, Eberhardt MS, Brancati FL (2003) Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 157:1092-1100
19. Batty GD, Shipley MJ, Marmot M, Smith GD (2004) Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control 15:873-881
20. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6:863-873
21. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194-202
22. Ulmer H, Kelleher C, Diem G, Concin H (2004) Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality. J Womens Health (Larchmt) 13:41-53
23. Reinauer H, Home PD, Kanagasabapathy AS, Heuck C-C, World Health Organization (2002) Laboratory diagnosis and monitoring of diabetes mellitus. World Health Organization, Geneva
24. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, and all at the International Agency for Research on Cancer, Lyon France (2003) Cancer incidence in five continents, vol VIII, ISBN 92832 21559
25. Oberaigner W, Concin H, and Mathis G (2003) aks Report, vol 2; http://www.aks.or.at/berichte
26. WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series 894:i-253
27. Macinnis RJ, English DR, Gertig DM, Hopper JL, Giles GG (2004) Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 13:2117-2125
28. Rapp K, Schroeder J, Klenk J et al (2005) Obesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria. Br J Cancer 93:1062-1067
29. Ish-Shalom D, Christoffersen CT, Vorwerk P et al (1997) Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40(Suppl 2):S25-S31
30. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244
31. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579-591
32. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El Serag HB (2005) Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54:533-539
33. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
34. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes - a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241:471-475
35. Natazuka T, Manabe Y, Kono M, Murayama T, Matsui T, Chihara K (1994) Association between non-insulin dependent diabetes mellitus and non-Hodgkin's lymphoma. BMJ 309:1269
36. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF Jr (1984) Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119:510-515
37. La Vecchia C, Negri E, D'Avanzo B, Savoldelli R, Franceschi S (1991) Genital and urinary tract diseases and bladder cancer. Cancer Res 51:629-631
38. Dosemeci M, Wacholder S, Lubin JH (1990) Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 132:746-748
39. Correa-Villasenor A, Stewart WF, Franco-Marina F, Seacat H (1995) Bias from nondifferential misclassification in case-control studies with three exposure levels. Epidemiology 6:276-281
40. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431
41. Ulmer H, Diem G, Bischof HP, Ruttmann E, Concin H (2001) Recent trends and sociodemographic distribution of cardiovascular risk factors: results from two population surveys in the Austrian WHO CINDI demonstration area. Wien Klin Wochenschr 113:573-579